Small molecule modulators of IL-17

The present invention relates to a compound according to formula I (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases,...

Full description

Saved in:
Bibliographic Details
Main Authors Jessiman, Alan Stuart, Jørgensen, Lars, Johnson, Patrick Stephen, Andrews, Mark, Burhardt, Mia Nørreskov, Larsen, Mogens, Andersen, Peter, Dack, Kevin Neil, Liang, Xifu
Format Patent
LanguageEnglish
Published 05.07.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a compound according to formula I (I) and pharmaceutically acceptable salts, hydrates, or solvates thereof. The invention further relates to said compounds for use in therapy, to pharmaceutical compositions comprising said compounds, to methods of treating diseases, e.g. dermal diseases, with said compounds, and to the use of said compounds in the manufacture of medicaments.
Bibliography:Application Number: US201916765143